PD-L1 quantification across tumor types using the reverse phase protein microarray: implications for precision medicine.
Baldelli E, Hodge KA, Bellezza G, Shah NJ, Gambara G, Sidoni A, Mandarano M, Ruhunusiri C, Dunetz B, Abu-Khalaf M, Wulfkuhle J, Gallagher RI, Liotta L, de Bono J, Mehra N, Riisnaes R, Ravaggi A, Odicino F, Sereni MI, Blackburn M, Zupa A, Improta G, Demsko P, Crino' L, Ludovini V, Giaccone G, Petricoin EF, Pierobon M.
Baldelli E, et al. Among authors: shah nj.
J Immunother Cancer. 2021 Oct;9(10):e002179. doi: 10.1136/jitc-2020-002179.
J Immunother Cancer. 2021.
PMID: 34620701
Free PMC article.